Abbott RD, Ando F, Masaki KH, et al. Dietary magnesium intake and the future
risk of coronary heart disease (the Honolulu Heart Program). Am J Cardiol.
2003;92(6):665-669.
Abrams J. C-reactive protein, inflammation, and coronary risk: an update.
Cardiol Clin. 2003;21(3):327-331.
Ackermann RT, Mulrow CD, Ramirez G, Gardner CD, Morbidoni L, Lawrence VA.
Garlic shows promise for improving some cardiovascular risk factors. Arch
Intern Med. 2001;161:813-824.
Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of
sudden cardiac death. JAMA. 1998;279(1):23-28.
Alissa EM, Bahijri SM, Ferns GA. The controversy surrounding selenium and
cardiovascular disease: a review of the evidence. Med Sci Monit.
2003;9(1):RA9-18.
Anderson TJ. Nitric oxide, atherosclerosis and the clinical relevance of
endothelial dysfunction. Heart Fail Rev. 2003;8(1):71-86.
Angerer P, von Schacky C. n-3 polyunsaturated fatty acids and the
cardiovascular system. Curr Opin Lipidol. 2000;11(1):57-63.
Antoniades C, Tousoulis D, Tentolouris C, Toutouzas P, Stefanadis. Oxidative
stress, antioxidant vitamins, and atherosclerosis. From basic research to
clinical practice. Herz. 2003;28(7):628-638.
Arnow WS. C-reactive protein. Should it be considered a coronary risk factor?
Geriatrics. 2003;58(5):19-22,25.
Arsenian, MA. Carnitine and its derivatives in cardiovascular disease.
Progr Cardiovasc Dis. 1997;40:3:265-286.
Asai A, Miyazawa T. Dietary curcuminoids prevent high-fat diet-induced lipid
accumulation in rat liver and epididymal adipose tissue. J Nutr.
2001;131(11):2932-2935.
Bahorun T, Trotin F, Pommery J, Vasseur J, Pinkas M. Antioxidant activities
of Crataegus monogyna extracts. Planta Med. 1994;60:323-328.
Bahrke MS, Morgan WR. Evaluation of the ergogenic properties of ginseng: an
update. Sports Med. 2000;29(2):113-133.
Barefoot JC, Burg MM, Carney RM, et al. Aspects of social support associated
with depression at hospitalization and follow-up assessment among cardiac
patients. J Cardiopulm Rehabil. 2003;23(6):404-412.
Berman LF, Blumenthal J, Burg M, et al. Effects of treating depression and
low perceived social support on clinical events after myocardial infacrction:
the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized
Trial. JAMA. 2003;289(23):3106-3116.
Berthold HK, Sudhop T. Galic preparation for prevention of atherosclerosis.
Curr Opin Lipidol. 1998;9(6):565-569.
Berthold HK, Sudhop T, von Bergmann K. Effect of a garlic oil preparation on
serum lipoproteins and cholesterol metabolism. JAMA. 1998;279.
Blake GJ. Inflammatory biomarkers of the patient with myocardial
insufficiency. Curr Opin Crit Care. 2003;9(5):369-374.
Blumenthal JA, O'Connor C, Hinderliter A, et al. Psychosocial factors and
coronary disease. A national multicenter clinical trial (ENRICHD) with a North
Carolina focus. NC MED J. 1997;58(6):440-444.
Buckley MS, Goff AD, Knapp, WE. Fish oil interaction with warfarin. Ann
Pharmacother. 2004;38(1):50-52.
Carney RM, Blumenthal JA, Catellier D, et al. Depression as a risk factor for
mortality after acute myocardial infarction. Am J Cardiol.
2003;92(11):1277-1281.
Chan MM, Mattiacci JA, Hwang HS, Shah A, Fong D. Synergy between ethanol and
grape polyphenols, quercetin, and resveratrol, in the inhibition of the
inducible nitric oxide synthase pathway. Bio Pharm.
2000;60(10):1539-1548.
Cheung MC, Zhao XQ, Chait A, Albers JJ, Brown BG. Antioxidant supplements
block the response of HDL to simvastatin-niacin therapy in patients with
coronary heart disease and low HDL. Arterioscler Thromb Vasc Biol.
2001;21(8):1320-1326.
Chiu YJ, Chi A, Reid IA. Cardiovascular and endocrine effects of acupuncture
in hypertensive patients. Clin Exper Hypertens. 1997;19(7):1047-1063.
Collaborative Group of the Primary Prevention Project. Low-dose aspirin and
vitamin E in people at cardiovascular risk: a randomised trial in general
practice. Lancet. 2001;357:89-95.
Connor SL, Connor WE. Are fish oils beneficial in the prevention and
treatment of coronary artery disease? Am J Clin Nutr.
1997;66(suppl):1020S-1031S.
Curcuma longa (turmeric). Monograph. Altern Med Rev. 2001;6
Suppl:S62-S66.
de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic
acid-rich diet in secondary prevention of coronary heart disease. Lancet.
1994;343:1454-1459.
de Logeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N.
Mediterranean diet, traditional risk factors, and the rate of cardiovascular
complications after myocardial infarction: final report of the Lyon Diet Heart
Study. Circulation. 1999;99(6):779-785.
Diaz MN, Frei B, Vita JA, Keaney JF. Antioxidants and atherosclerotic heart
disease. N Engl J Med. 1997;337(16):408-416.
Eikelboom JW, Lonn E, Genest J, Hankey G, Yusuf S. Homocysteine and
cardiovascular disease: a critical review of the epidemiologic evidence. Ann
Intern Med. 1999;131:363-375.
Elgharib N, Chi DS, Younis W, Wehbe S, Krishnaswamy G. C-reactive protein as
a novel biomarker. Reactant can flag atherosclerosis and help predict cardiac
events. Postgrad Med. 2003;114(6):39-44; quiz 16.
Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample
of the United States population. Epidemiology. 1992;3(3):194-202.
Erbs S, Gielen S, Linke A, et al. Improvement of peripheral endothelial
dysfunction by acute vitamin C application: different effects in patients with
coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart
J. 2003;146(2):280-285.
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol
in Adults. Executive summary of the third report of the National Cholesterol
Education Program (NCEP) expert panel on detection, evaluation, and treatment of
high blood cholesterol in adults (Adult Treatment Panel III). JAMA.
2001;285(19):2486-2497.
Fatty fish consumption and ischemic heart disease mortality in older adults:
The cardiovascular heart study. Presented at the American Heart Association's
41st annual conference on cardiovascular disease epidemiology and prevention.
AHA. 2001.
FDA Talk Paper. T99-48. FDA approves new health claim for soy protein and
coronary heart disease. October 20, 1999.
Filshie J, White A. The clinical use of, and evidence for, acupuncture in the
medical systems. In: Filshie J, White A, eds. Medical Acupuncture: A Western
Scientific Approach. Edinburgh, UK: Churchill-Livingstone; 1998:234-236.
Frasure-Smith N, Lesperance F. Depression - a
cardiac risk factor in search of a treatment. JAMA.
2003;289(23):3171-3173.
Fugh-Berman A. Herbs and dietary supplements in the prevention and treatment
of cardiovascular disease. Prev Cardiology. 2000;3:24-32.
Fung TT, Hu FB. Plant-based diets: what should be on the plate? Am J Clin
Nutr. 2003;78(3):357-358.
Geleijnse JM, Launer LJ, Hofman A, Pols HA, Witteman JCM. Tea flavonoids may
protect against atherosclerosis: the Rotterdam study. Arch Intern Med.
1999;159:2170-2174.
Geleijnse JM, Launer LJ, Van der Kuip DA, Hofman A, Witteman JC. Inverse
association of tea and flavonoid intakes with incident myocardial infarction:
the Rotterdam Study. Am J Clin Nutr. 2002;75(5):880-886.
GISSI-Prevenzione Investigators. Dietary supplementation with n-3
polyunsaturated fatty acids and vitamin E after myocardial infarction: results
of the GISSI-Prevenzione trial. Lancet. 1999;354:447-455.
Glassman AH, O'Connor CM, Califf RM, et al. Sertraline treatment of major
depression in patients with acute MI or unstable angina. JAMA.
2002;288(6):701-709.
Gokce N, Keaney JF, Frei B, et al. Long-term ascorbic acid administration
reverses endothelial vasomotor dysfunction in patients with coronary artery
disease. Circulation. 1999;99:3234-3240.
Gonzales MA, Selwyn AP. Endothelial function, inflammation, and prognosis in
cardiovascular disease. Am J Med. 2003; 115 Suppl 8A:99S-106S.
Gotto AM. Antioxidants, statins, and atherosclerosis. J Am Coll
Cardiol. 2003;41(7);1205-1210.
Grant PJ. The genetics of atherothrombotic disorders: a clinician's view.
J Thromb Haemost. 2003;1(7):1381-1390.
Guo H, Lee JD, Ueda T, Cheng J, Shan J, Wang J. Hyperhomocysteinaemia and
folic acid supplementation in patients with high risk of coronary artery
disease. Indian J Med Res. 2004;119:33-37.
Guo H, Lee JD, Ueda T, Shan J, Wang J. Plasma homocysteine levels in patients
with early coronary artery stenosis and high risk factors. Jpn Heart J.
2003;44(6):865-871.
Hak AE, Stampfer MJ, Campos H, Sesso HD, Gaziano JM, Willett W, Manson J.
Plasma carotenoids and tocopherols and risk of myocardial infarction in a
low-risk population of US male physicians. Circulation.
2003;108(7):802-807.
Harper CR, Jacobson TA. The fats of life: the role of omega-3 fatty acids in
the prevention of coronary heart disease. Arch Intern Med.
2001;161(18):2185-2192.
Harris WS, Gowda M, Kolb JW, et al. A randomized, controlled trial of the
effects of remote, intercessory prayer on outcomes in patients admitted to the
coronary care unit. Arch Intern Med. 1999;159(19):2273-2278.
Heart Prtoection Study Collaborative Group. MRC/BHF heart Protection Study of
antioxidant vitamin supplementation in 20,536 high-risk individuals: a
randomised placebo-controlled trial. Lancet. 2002;360(9326):23-33.
Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative
therapies and warfarin. Am J Health Syst Pharm.
2000;57(13):1221-1227.
Heinecke JW. Clinical trials of vitamin E in coronary artery disease: is it
time to reconsider the low-density lipoprotein oxidation hypothesis? Curr
Atheroscler Rep. 2003;5(2):83-87.
Hernandez-Reif M, Field T, Krasnegor J, Theakston H, Hossain Z, Burman I.
High blood pressure and associated symptoms were reduced by massage therapy.
J Bodywork Movement Ther. 2000; 4:31-38
Higgins JP. Chlamydia pneumoniae and coronary artery disease: the antibiotic
trials. Mayo Clin Proc. 2003;78(3):321-332.
Hu FB, Stampfer MJ, Manson JE et al. Dietary intake of alpha-linolenic acid
and risk of fatal ischemic heart disease among women. Am J Clin Nutr.
1999;69:890-897.
Iliceto S, Scrutinio D, Bruzzi P, et al. Effects of L-carnitine
administration on left ventricular remodeling after acute anterior myocardial
infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico
(CEDIM) Trial. J Am Coll Cardiol. 1995;26:380.
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
ISIS-4: a randomized factorial trial assessing early oral captropril, oral
mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected
acute myocardial infarction. Lancet. 1995;345(8951):669-685.
Kelly GS. L-Carnitine: therapeutic applications of a conditionally-essential
amino acid. Alt Med Rev. 1998;3:345-60.
Kelly GS. Nutritional and botanical interventions to assist with the
adaptation to stress. Alt Med Rev. 1999;4(4):249-265.
Kendler BS. Recent nutritional approaches to the prevention and therapy of
cardiovasular disease. Prog Cardiovasc Nurs. 1997;12(3):3-23.
Kinlay S, Behrendt D, Fang JC, et al. Long-term effect of combined vitamins E
and C on coronary and peripheral endothelial function. J Am Coll Cardiol.
2004;43(4):629-634.
Klevay LM, Milne DB. Low dietary magnesium increases supraventricular ectopy.
Am J Clin Nutr. 2002;75(3):550-554.
Koh KB, Choe KO, An SK. Anger and coronary calcification in individuals with
and without risk factors of coronary artery disease. Yonsei Med J.
2003;30:44(5):793-799.
Koenig W. Inflammation and coronary heart disease: an overview. Cardiol
Rev. 2001;9(1):31-35.
Koscielny J, Klubendorf D, Latza R, Schmitt R, Radtke H, Siegel G,
Kiesewetter H. The antiatherosclerotic effect of Allium sativum.
Atherosclerosis. 1999;144:237-249.
Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, et al.
AHA Scientific Statement: AHA dietary guidelines revision 2000: A statement for
healthcare professionals from the nutrition committee of the American Heart
Association. Circulation. 2000;102(18):2284-2299.
Kris-Etherton P, Eckel RH, Howard BV, St. Jeor S, Bazzare TL. AHA science
advisory: Lyon diet heart study. Benefits of a Mediterranean-style, National
Cholesterol Education Program/American Heart Association Step I dietary pattern
on cardiovascular disease. Circulation. 2001;103:1823-1825.
Kruzel T. The Homeopathic Emergency Guide. Berkeley, Calif: North
Atlantic Books; 1992:58-60.
Kurono Y, Egawa M, Yano T, Shimoo K. The effect of acupuncture on the
coronary arteries as evaluated by coronary angiography: a preliminary report.
Am J Chin Med. 2002;30(2-3):387-396.
Langsjoen P, Langsjoen A. Overview of the use of CoQ10 in cardiovascular
disease. BioFactors. 1999;9:273-284.
Laplaud PM, Lelubre A, Chapman MJ. Antioxidant action of Vaccinium myrtillus
extract on human low density lipoproteins in vitro: initial observations.
Fundam Clin Pharmacol. 1997;11(1):35-40.
Lee BJ, Lin PT< Liaw YP, Chang SJ, Cheng CH, Huang YC. Homocysteine and
risk of coronary arter disease: Folate is the important determinant of plasma
homocysteine concentration. Nutrition. 2003;19(7-8):577-583.
Lefevre M, Kris-Etherton PM, Zhao G, Tracy RP. Dietary fatty acids,
hemostasis, and cardiovascular disease risk. J Am Diet Assoc.
2004;104(3):410-419, quiz 492.
Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney FJ, Vita JA. Ascorbic
acid reverses endothelial vasomotor dysfunction in patients with coronary artery
disease. Circulation. 1996;93:1107-1113.
Liem A, Reynierse-Buitenwerf GH, Zwinderman AH, Jukema JW, van Veldhuisen DJ.
Secondary prevention with folic acid: effects on clinical outcomes. J Am Coll
Cardiol. 2003;41(12):2105-2113.
Linton MF, Fazio S; National Cholesterol Education Program (NCEP)-the third
Adult Treatment Panel (ATP III). Am J Cardiol. 2003;92(1A):19i-26i.
Little D. An intervention to treat depression and increase social support did
not prolong event-free survival in coronary heart disease. ACP J Club.
2004;140(1):8.
Lonn E, Yusuf S, Hoogwerf B, et al. Effects of vitamin E on cardiovascular
and microvascular outcomes in high-risk patienst with diabetes: results of the
HOPE study and MICRO-HOPE substudy. Diabetes Care. 2002;25(11):1919-1927.
Loster H, Miehe K, Punzel M, Stiller O, Pankau H, Schauer J. Prolonged oral
L-carnitine substitution increases bicycle ergometer performance in patients
with severe, ischemically induced cardiac insufficiency. Cardiovasc Drugs
Ther. 1999;13:537-546.
Loy MH, Rivlin RS. Garlic and cardiovascular disease. Nutr Clin Care.
2000;3(3):146-151.
Malinow MR, Bostom AG, Krauss RM. Homocysteine, diet, and cardiovascular
disease. A statement for healthcare professionals from the nutrition committee,
American Heart Association. Circulation. 1999;99:178-182.
Marcovina SM, Koschinsky ML, Albers JJ, Skarlatos S. Report of the National
Heart, Lung, and Blood Institute Workshop on Lipoprotein (a) and Cardiovascular
Disease: recent advances and future directions. Clin Chem.
2003;49(11):1785-1796.
Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of
cardiovascular disease. Arch Intern Med.
1998;158:2225-2234.
Matetzky S, Freimark DD, Ben-Ami S, et al. Association of elevated
homocysteine levels with a higher risk of recurrent coronary events and
mortality in patients with acute myocardial infarction. Arch Intern Med.
2003;163(16):1933-1937.
Maurer HR. Bromelain: biochemistry, pharmacology, and medical use. Cell
Mol Life Sci. 2001;58(9):1234-1245.
McKenna DJ, Hughes K, Jones K. Green tea monograph. Alt Ther.
2000;6(3):61-84.
Mendes de Leon CF, Dilillo V, Czajkowski S, et al. Enhancing Recovery in
Coronary Heart Disease (ENRICHD) Pilot Study. Psychosocial characteristics after
acute myocardial infarction: the ENRICHD pilot study. Enhancing Recovery in
Coronary Heart Disease. J Cardiopulm Rehabil. 2001;21(6):353-362.
Meydani M. Omega-3 fatty acids alter soluble markers of endothelial function
in coronary heart disease patients. Nutr Rev. 2000;58(2 pt 1):56-59.
Milani RV, Lavie CJ, Mehra MR. Reduction in C-reactive protein through
cardiac rehabilitation and exercise training. J Am Coll Cardiol.
2004;43(6):1056-1061.
Miller AL. Botanical influences on cardiovascular disease. Altern Med
Review. 1998;3(6):422-431.
Miura Y, Chiba T, Tomita I, et al. Tea catechins prevent the development of
atherosclerosis in apoprotein E-deficient mice. J Nutr.
2001;131(1):27-32.
Meagher EA. Treatment of atherosclerosis in the new millennium: is there a
role for vitamin E? Prev Cardiol. 2003;6(2):85-90.
Muhlestein JB, Anderson JL. Chronic infection and coronary artery disease.
Cardiol Clin. 2003;21(3):333-362.
Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable
patient: a call for new definitions and risk assessment strategies: Part II.
Circulation. 2003;108(15):1772-1778.
Negri E, La Vecchia C, Pelucchi C, Bertuzzi M, Tavani A. Fiber intake and
risk of nonfatal acute myocardial infarction. Eur J Clin Nutr.
2003;57(3):464-470.
Nyyssonen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin C
deficiency and risk of myocardial infarction: prospective population study of
men from eastern Finland. BMJ. 1997;314:634-638.
Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson JE, Willet WC. Dietary
carotenoids and risk of coronary artery disease in women. Am J Clin Nutr.
2003;77(6):1390-1399.
Prasad K. Dietary flaxseed in prevention of hypercholesterolemic
atherosclerosis. Atherosclerosis.
1997;132(1):69-76.
Price JR. Treating low perceived social support and depression after
myocardial infarction does not increase event-free survival. Evid Based Ment
Health. 2004;7(1):22.
Pruthi S, Allison TG, Hensrud DD. Vitamin E supplementation in the prevention
of coronary heart disease. Mayo Clin Proc. 2001;76:1131-1136.
Rahman K. Historical perspective on garlic and cardiovascular disease. J
Nutr. 2001;131(3s):977S-979S.
Ramirez-Tortosa MC, Mesa MD, Aguilera MC, et al. Oral administration of a
turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in
rabbits with experimental atherosclerosis. Atherosclerosis.
1999;147(2):371-378.
Reed J. Cranberry flavonoids, atherosclerosis and cardiovascular health.
Crit Rev Food Sci Nutr. 2002;42(3 Suppl):301-316.
Rigelsky JM, Sweet BV. Hawthorn: pharmacology and therapeutic uses. Am J
Health Syst Pharm. 2002;59(5):417-422.
Rimm EB, Stampfer MJ, Ascherio A, Giovannucii E, Colditz GA, Willett WC.
Vitamin E consumption and the risk of coronary heart disease in men.
NEJM. 1993;328(20):1450-1456.
Rimm EB, Willett WC, Hu FB, et al. Folate and vitamin B6 from diet and
supplements in relation to risk of coronary heart disease among women.
JAMA. 1998;279:359-364.
Roberts L, Ahmed I, Hall S. Intercessory prayer for the alleviation of ill
health. Cochrane Database Syst Rev. 2000;(2):CD000368.
Robinson K, Arheart K, Refsum H, et al. Low circulating folate and vitamin B6
concentrations. Risk factors for stroke, peripheral vascular disease, and
coronary artery disease. Circulation. 1998;97:437-443.
Rodriguez-Porcel M, Lerman LO, Herrmann J, Sawamura T, Napoli C, Lerman A.
Hypercholesterolemia and hypertension have synergistic deleterious effects on
coronary endothelial function. Arterioscler Thromb Vasc Biol.
2003;23(5):885-891.
Roe E, Nunez I, Perez-Heras A, et al. A walnut diet improves endothelial
function in hypercholesterolemic subjects.Circulation.
2004;109(13):1609-1614.
Rosenson RS, Koenig W. Utility of inflammatory markers in the management of
coronary artery disease. Am J Cardiol. 2003;92(1A):10i-18i.
Rotblatt M, Ziment I. Evidence-Based Herbal Medicine. Philadelphia,
PA: Hanley & Belfus, Inc; 2002:231-235.
Ruburg FL, Leooplold JA, Loscalzo J. Atheothrombosis: plaque instability and
thrombogenesis. Prog Cardiovasc Dis. 2002;44(5):381-394.
Sasazuki S, Kodama H, Yoshimasu K et al. Relation between green tea
consumption and the severity of coronary atherosclerosis among Japanese men and
women. Ann Epidemiol. 2000;10:401-408.
Serebruany VL, Ordonez JV, Herzog WR, et al. Dietary coenzyme Q10
supplementation alters platelet size and inhibits human vitronectin (CD51/CD61)
receptor expression. J Cardiovasc Pharmacol. 1997;29:16-22.
Scanu AM. Lipoprotein(a) and the atherothrombotic process: mechanistic
insights and clinical implications. Curr Atheroscler Rep.
2003;5(2):106-113.
Schussler M, Holzl J, Fricke U. Myocardial effects of flavonoids from
crataegus species. Arzneimittelforschung.
1995;45:842-845.
Shah SH, Newby LK. C-reactive protein: a novel marker of cardiovascular risk.
Cardiol Rev. 2003;11(4):169-179.
Shechter M. Does magnesium have a role in the treatment of patients with
coronary artery disease? Am J Cardiovasc Drugs. 2003;3(4):231-239.
Sheps DS, Freedland KE, Golden RN, et al. ENRICHD and SADHART: implications
for future biobehavioral intervention efforts. Psychosom Med.
2003;65(1):1-2.
Silagy CA, Neil AW. A meta-analysis of the effect of garlic on blood
pressure. J Hypertens 1994;12:463-468.
Simon JA, Murtaugh MA, Gross MD, Loria CM, Hulley SB, Jacobs DR Jr. Relation
of ascorbic acid to coronary artery calcium: the Coronary Artery Risk
Development in Young Adults Study. Am J Epidemiol.
2004;159(6):581-588.
Singh RB, Neki NS, Kartikey K, et al. Effect of coenzyme Q10 on risk of
atherosclerosis in patients with recent myocardial infarction. Mol Cell
Biochem. 2003;246(1-2):75-82.
Singh RB, Niaz MA, Agarwal P, et. al. A randomised, double-blind,
placebo-controlled trial of L-carnitine in suspected acute myocardial
infarction. Postgrad Med. 1996;72:45-50.
Singh RB, Niaz MA, Agarwal P, et. al. Effect of antioxidant-rich foods on
plasma ascorbic acid, cardiac enzyme, and lipid peroxide levels in patients
hospitalized with acute myocardial infarction. J Am Diet Assoc.
1995;95:775-780.
Singh RB, Singh NK, Niaz MA, Sharma JP. Effect of treatment with magnesium
and potassium on mortality and reinfarction rate of patients with suspected
acute myocardial infarction. Int J Clin Pharmacol Thera. 1996;34:219-225.
Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind
placebo-controlled trial of coenzyme Q10 in patients with acute myocardial
infarction. Cardiovasc Drugs Ther. 1998;12:347-353.
Sobczak AJ. The effects of tobacco smoke on the homocysteine level
- a risk factor of therosclerosis. Addict Biol.
2003;8(2):147-158.
Soltero-Perez IF. Thinking intelligently about therpy of atherosclerosis.
Am J Ther. 2003;10(6):429-437.
Spigelski D, Jones PJ. Efficacy of garlic supplementation in lowering serum
cholesterol levels. Nutr Rev. 2001;59(7):236-241.
Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of
coronary heart disease in women through diet and lifestyle. NEJM.
2000;343(1):16-22.
Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia.
Ann Intern Med. 2000;133(6):420-429.
Strike PC, Steptoe A. Psychosocial facotrs in the development of coronary
artery disease. Prog Cardiovasc Dis. 2004;46(4):337-347.
Sum CF, Winocour PH, Agius L, et al. Does oral L-carnitine alter plasma
triglyceride levels in hypertriglyceridemic subjects with or without non-insulin
dependent diabetes mellitus. Diabetes Nutr Metab Clin Exp.
1992;5:175-181.
Sung J, Han KH, Zo JH, Park HJ, Kim CH, Oh B-H. Effects of red ginseng upon
vascular endothelial function in patients with essential hypertension. Am J
Chin Med. 2000;28(2):205-216.
Superko HR, Krauss RM. Garlic powder, effect on plasma lipids, postprandial
lipemia, low-density lipoprotein particle size, high-density lipoprotein
subclass distribution and lipoprotein(a). J Am Coll Cardiol.
2000;35(2):321-326.
Tanguy S, Toufektsian MC, Besse S, Ducros V, De Leiris J, Boucher F. Dietary
selenium intake affects cardiac susceptibility to ischaemia/reperfusion in male
senescent rats. Age Ageing. 2003;32(30:273-278.
Tokmakidis SP, Volaklis KA. Training and detraining effects of a
combined-strength and aerobic exercise program on blood lipids in patients with
coronary artery disease. J Cardiopulm Rehabil. 2003;23(3):193-200.
Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA. Inflammatory
and thrombotic mechanisms in coronary atherosclerosis. Heart.
2003;89(9):993-997.
Vaes LP, Chyka PA. Interactions of warfarin with garlic, ginger, ginkgo, or
ginseng: nature of the evidence. Ann Pharmacother.
2000;34(12):1478-1482.
Valgimigli M, Merli E, Malagutti P, et al. Endothelial dysfunction in acute
and chronic coronary syndromes: evidence for a pathogenetic role of oxidative
stress. Arch Biochem Biophys. 2003;420(2):255-261.
Vermeulen EGJ, Stehouwer CDA, Twisk JWR, et al. Effect of
homocysteine-lowering treatment with folic acid plus vitamin B6 on progression
of subclinical atherosclerosis: a randomised, placebo-controlled trial.
Lancet. 2000;355:517-522.
Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene
on the incidence of primary nonfatal myocardial infaction and fatal coronary
heart disease. Arch Intern Med. 1998;158:668-675.
Von Schacky C, Angere P, Kothny W, Theisen K, Mudra H. The effect of dietary
omega-3 fatty acids on coronary atherosclerosis. Ann Intern Med.
1999;130:554-562.
Wang HX, NG TB. Natural products with hypoglycemic, hypotensive,
hypocholesterolemic, antiatherosclerotic and antithrombotic activities. Life
Sci. 1999;65(25):2663-2677.
Watkins LL, Schneiderman N, Blumenthal JA, et al. Cognitive and somatic
symptoms of depression are associated with medical comorbidity in patients after
acute myocardial infarction. Am Heart J. 2003;146(1):48-54.
Yang TTC, Koo MWI. Chinese green tea lowers cholesterol level through an
increase in fecal lipid excreiton. Life Sci. 1999:66:5:411-423.
Yeh ET, Palusinski RP. C-reactive protein: the pawn has been promoted to
queen. Curr Atheroscler Rep. 2003;5(2):101-105.
Yologlu S, Sezgin AT, Ozdemir R, et al. Identifying risk factors in a mostly
overweight patient population with coronary artery disease. Angiology.
2003;54(2):181-186.
Yoshizawa K, Ascherio A, Morris JS, et al. Prospective study of selsnium
levels in toenails and risk of coronary heart disease in men. Am J
Epidemiol. 2003;158(9):852-860.
Zambón D, Sabate J, Munoz S, et al. Substituting walnuts for monounsaturated
fat improves the serum lipid profile of hypercholesterolemic men and women.
Ann Intern Med. 2000;132:538-546.